Ensoma Announces Closing of Twelve Bio Acquisition

Ensoma, a genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system to cure diseases from within, today announced the closing of its

Related Keywords

Boston ,Massachusetts ,United States ,Denmark ,Copenhagen ,Køavn ,Danish ,Katie Engleman ,Shengdarq Tsai ,Stefano Stella ,Guillermo Montoya ,Schwierige Zeiten ,Danish Business Authority ,Twelve Bio Aps ,Twelve Bio ,Ensoma ,Nnounces ,Closing ,Twelve ,Cquisition ,